During the past decade, Instituto de Oncologia Saint Gallen conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Oncologia Saint Gallen" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Oncologia Saint Gallen" are "Abiraterone Acetate" (1 trials), "Androgens" (1 trials), "Antineoplastic Agents" (1 trials), "Antineoplastic Agents, Hormonal" (1 trials) and "Cyclin-Dependent Kinase 4" (1 trials). Many other conditions were trialed in "Instituto de Oncologia Saint Gallen" in a lesser frequency.

Most popular intervention types in "Instituto de Oncologia Saint Gallen" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Abiraterone" (1 trials), "Encorafenib and Binimetinib" (1 trials), "Placebo for Abemaciclib" (1 trials) and "Placebo to match Encorafenib ; Placebo to match Binimetinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Oncologia Saint Gallen" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Instituto de Oncologia Saint Gallen". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Instituto de Oncologia Saint Gallen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Oncologia Saint Gallen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".